1. Home
  2. POAI vs JCSE Comparison

POAI vs JCSE Comparison

Compare POAI & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • JCSE
  • Stock Information
  • Founded
  • POAI 2002
  • JCSE 1999
  • Country
  • POAI United States
  • JCSE Singapore
  • Employees
  • POAI N/A
  • JCSE N/A
  • Industry
  • POAI Industrial Specialties
  • JCSE Miscellaneous manufacturing industries
  • Sector
  • POAI Health Care
  • JCSE Consumer Discretionary
  • Exchange
  • POAI Nasdaq
  • JCSE Nasdaq
  • Market Cap
  • POAI 8.5M
  • JCSE 7.6M
  • IPO Year
  • POAI N/A
  • JCSE 2022
  • Fundamental
  • Price
  • POAI $1.46
  • JCSE $1.62
  • Analyst Decision
  • POAI Hold
  • JCSE
  • Analyst Count
  • POAI 1
  • JCSE 0
  • Target Price
  • POAI N/A
  • JCSE N/A
  • AVG Volume (30 Days)
  • POAI 2.9M
  • JCSE 15.2K
  • Earning Date
  • POAI 03-27-2025
  • JCSE 10-30-2024
  • Dividend Yield
  • POAI N/A
  • JCSE 5.59%
  • EPS Growth
  • POAI N/A
  • JCSE N/A
  • EPS
  • POAI N/A
  • JCSE 0.12
  • Revenue
  • POAI $1,484,223.00
  • JCSE $14,723,999.00
  • Revenue This Year
  • POAI N/A
  • JCSE N/A
  • Revenue Next Year
  • POAI $569.48
  • JCSE N/A
  • P/E Ratio
  • POAI N/A
  • JCSE $13.53
  • Revenue Growth
  • POAI N/A
  • JCSE N/A
  • 52 Week Low
  • POAI $0.55
  • JCSE $0.60
  • 52 Week High
  • POAI $3.76
  • JCSE $2.39
  • Technical
  • Relative Strength Index (RSI)
  • POAI 59.80
  • JCSE 65.83
  • Support Level
  • POAI $1.36
  • JCSE $1.43
  • Resistance Level
  • POAI $1.58
  • JCSE $1.71
  • Average True Range (ATR)
  • POAI 0.21
  • JCSE 0.08
  • MACD
  • POAI -0.01
  • JCSE 0.02
  • Stochastic Oscillator
  • POAI 30.58
  • JCSE 85.71

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.

Share on Social Networks: